Sign In
Get Clay Free →

Suggestions

    Richard Schwartz

    Associate at Cravath, Swaine & Moore LLP

    Richard E. Schwartz is an associate at Cravath, Swaine & Moore LLP, a prestigious law firm.13 He specializes in M&A (mergers and acquisitions) matters and has been involved in several high-profile transactions.13 Schwartz joined Cravath in 2017 and previously worked as a summer associate at the firm.5

    Some notable deals Schwartz has worked on include:

    1. CymaBay Therapeutics' $4.3 billion acquisition by Gilead Sciences (February 2024)1
    2. GasLog Ltd.'s acquisition of GasLog Partners (April 2023)2
    3. Lindsay Goldberg's acquisition of The Kleinfelder Group (September 2023)3

    Schwartz has also contributed to securities matters, such as the State of Israel's $3 billion registered notes offering.6

    As of June 2024, Schwartz appears to have moved to Paul, Weiss, Rifkind, Wharton & Garrison LLP as an associate, based in New York.45

    Highlights

    Jun 10 · paulweiss.com
    Richard E. Schwartz, Associate | Paul, Weiss
    Sep 19 · cravath.com
    Lindsay Goldberg's Acquisition of The Kleinfelder Group
    Apr 6 · cravath.com
    GasLog Ltd.'s Acquisition of GasLog Partners

    Related Questions

    What types of deals has Richard Schwartz worked on at Cravath, Swaine & Moore LLP?
    How long has Richard Schwartz been an associate at Cravath, Swaine & Moore LLP?
    What is Richard Schwartz's role in the acquisition of CymaBay by Gilead Sciences?
    Has Richard Schwartz worked on any other major M&A deals recently?
    What is Richard Schwartz's educational background?
    Richard Schwartz
    Richard Schwartz, photo 1
    Richard Schwartz, photo 2
    Get intro to Richard
    Add to my network

    Location

    New York, New York, United States